Search results for: ripretinib

Home/Search: ripretinib
18 05, 2020

FDA Approves QINLOCK (ripretinib) by Deciphera for 4L GIST Patients

By |2020-05-19T10:55:56-04:00May 18th, 2020|Clinical Trials, News|

The FDA approved QINLOCKTM (ripretinib) for the treatment of adults with advanced gastrointestinal stromal tumor (GIST) who have received 3 or more prior treatments for their GIST.

14 02, 2020

Priority Review Granted for Ripretinib

By |2020-02-14T09:57:21-05:00February 14th, 2020|Drug Treatment, News|

Deciphera Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted their New Drug Application (NDA) for ripretinib for Priority Review. Ripretinib is an investigational broad-spectrum KIT and PDGFRa inhibitor for the treatment of patients with gastrointestinal stromal tumors (GIST).

14 08, 2019

Deciphera Releases Positive Trial Results for Ripretinib

By |2019-08-14T09:38:14-04:00August 14th, 2019|Drug Treatment, News, Research|

Deciphera Pharmaceuticals has released positive results from their INVICTUS Phase 3 Clinical Study of Ripretinib in patients with GIST. They have also updated results from the Phase 1 Study. Deciphera shared that "patients treated [...]

18 05, 2020

Qinlock for GIST

By |2020-05-18T12:02:31-04:00May 18th, 2020|

page created 5/18/2020 Qinlock Approved for 4th Line GIST Treatment May 15, 2020 QinlockTM (ripretinib) (Deciphera Pharmaceuticals, LLC) was approved by the FDA for adult patients with advanced gastrointestinal stromal tumor (GIST) who have [...]

28 04, 2020

Hope & Obstacles Along a GIST Journey

By |2020-04-28T15:10:16-04:00April 28th, 2020|Member Stories, News, Newsletter|

Many GIST patients around the world struggle with getting the treatment they need to survive and thrive. Arun Krishnan’s story illustrates how collaboration between patient groups and doctors across the globe can affect patient survival.

24 03, 2020

LRG Webcast Series: New Treatment Options for Advanced GIST & Concerns about the Coronavirus

By |2020-04-14T11:25:11-04:00March 24th, 2020|Drug Treatment, GIST Education, News, Webcast|

During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.

11 03, 2020

LRG Webcast Series: New Treatment Options for Advanced GIST & Concerns about the Coronavirus

By |2020-04-14T11:26:39-04:00March 11th, 2020|

During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.

Need a new search?

If you didn't find what you were looking for, try a new search!